Lars-gunnar Larsson

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8+ T cells.

Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8+ T cells.

Journal: Oncoimmunology

Published: April 30, 2026

CDK2 inhibition promotes neuronal differentiation in neuroblastoma.

CDK2 inhibition promotes neuronal differentiation in neuroblastoma.

Journal: Scientific reports

Published: May 24, 2025

A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosis.

A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosis.

Journal: Cell reports

Published: February 06, 2023

MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma.

MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma.

Journal: International journal of molecular sciences

Published: January 25, 2023

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule.

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule.

Journal: Frontiers in molecular biosciences

Published: November 29, 2021

MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding.

MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding.

Journal: Cancer research communications

Published: October 26, 2021

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.

Journal: Cancer research communications

Published: August 10, 2021

Methods to Study Myc-Regulated Cellular Senescence: An Update.

Methods to Study Myc-Regulated Cellular Senescence: An Update.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 21, 2021

Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.

Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.

Journal: Cell cycle (Georgetown, Tex.)

Published: December 28, 2020

The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells.

The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells.

Journal: Investigational new drugs

Published: September 07, 2020

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.

Journal: eLife

Published: April 16, 2020

MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.

MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.

Journal: Cell cycle (Georgetown, Tex.)

Published: December 12, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026